The Value of Pharmaceutical Care and the Healthcare Supply Chain

Amerisource Video 1

FiercePharma sits down with Bob Mauch, Group President of AmerisourceBergen, to discuss how distributors work to bring efficiencies and savings to the healthcare system. 

To learn more about how AmerisourceBergen operates as a distributor, moving products from point A to point B, check out how they create value in the supply chain here: https://www.amerisourcebergen.com/without-us.

Sponsored by Lubrizol Life Science

[Webinar] Cannabinoid Formulation - from Farm to Pharma

Wednesday, June 24, 2020 | 12pm ET / 9am PT

A handful of cannabinoid-based pharmaceutical products are on the market today, and an ever-growing number are in the global development pipeline. This webinar will explore key considerations in developing cannabinoid-based pharmaceutical products, including an overview of global pharmaceutical cannabinoid usage today, common challenges formulating with CBD and other cannabinoids, and more.
Read more on

Suggested Articles

AZ's tremelimumab has so far suffered a host of clinical failures. But new trial results show the company might be able to use the drug in a new way.

Roche may have just grabbed the first FDA nod for a checkpoint med in previously untreated liver cancer, but Merck is hoping it won’t be far behind.

Pfizer’s Ibrance has met with success in breast cancer since breaking onto the scene in 2015. But its first foray into early breast cancer was a bust.